LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE?

LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE?

The research objective is to determine the posterior probability of adverse cardiovascular events after elective coronary intervention in patients with ischemic heart disease (IHD) associated with type 2 diabetes, at high level of lipoprotein-associated phospholipase A2 (Lp-PLA2) in blood serum, as...

Full description

Bibliographic Details
Main Authors:	A. T. Teplyakov, A. V. Kuznetsova, N. V. Protopopova, A. V. Andriyanova, T. E. Suslova, O. N. Nasanova, V. V. Kalyuzhin
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2015-04-01
Series:	Bûlleten' Sibirskoj Mediciny
Subjects:	coronary artery disease type 2 diabetes mellitus percutaneous coronary intervention inflammation lipoprotein-associated phospholipase a2 prognosis
Online Access:	https://bulletin.tomsk.ru/jour/article/view/131

Similar Items

INFLUENCE OF RESISTIN ON THE COURSE OF ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: A. T. Teplyakov, et al.
Published: (2015-10-01)

Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
by: Yao-dong Ding, et al.
Published: (2020-05-01)

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
by: Hao Zhang, et al.
Published: (2020-06-01)

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
by: Yun-jie Yin, et al.
Published: (2020-06-01)

Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
by: Konstantinos Mourouzis, et al.
Published: (2021-02-01)

New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase
by: Fatmah A. S. Alasmary, et al.
Published: (2017-01-01)

Lipoprotein-associated Phospholipase A2 is Associated with Angiographic Coronary Artery Disease and Coronary Artery Risk Factors in the Elderly
by: Lini Dong, et al.
Published: (2015-06-01)

Alteration in lipoprotein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers
by: Ostadal Petr, et al.
Published: (2012-11-01)

Synergistic Effect of Lipoprotein-Associated Phospholipase A2 with Classical Risk Factors on Coronary Heart Disease: A Multi-Ethnic Study in China
by: Peng-Cheng Ge, et al.
Published: (2016-12-01)

RELATIONSHIP OF LIPOPROTEINE-ASSOCIATED PHOSPHOLIPASE A2 WITH CORONARY AND CAROTID ATHEROSCLEROSIS IN KIRGIZ ETHNIC GROUP
by: A. G. Polupanov, et al.
Published: (2014-11-01)

Effects of combined therapy with atorvastatin and polyunsaturated omega-3 fatty acids on lipid profile, lipoprotein-associated phospholipase A2 and thromboxane
by: G. F. Piksina, et al.
Published: (2010-10-01)

Lipoprotein-associated phospholipase A2 is increased in patients with impaired bone density
by: Kotaška Karel, et al.
Published: (2014-01-01)

Phospholipase A2 enzyme immobilization
by: B. Maroto, et al.
Published: (2000-06-01)

Activation of phospholipase D-2 by P2X7 agonists in rat submandibular gland acini
by: Encarnación Pérez-Andrés, et al.
Published: (2002-08-01)

Long-term results of coronary endovascular revascularisation with eluting sirolimus-stents in patients with coronary heart disease comorbid with type-2 diabetes mellitus: evidence from 18-month prospective study
by: A T Teplyakov, et al.
Published: (2009-05-01)

Secretory Phospholipases A2 in Plants
by: María Elisa Mariani, et al.
Published: (2019-07-01)

Mechanism(s) of activation of secretory phospholipase A2s in mouse keratinocytes
by: Bangyan Li-Stiles, et al.
Published: (1999-09-01)

Interplay between lipoproteins and bee venom phospholipase A2 in relation to their anti-plasmodium toxicity
by: Carole Guillaume, et al.
Published: (2006-07-01)

Long-term clinical results of coronary angioplasty with sirolimus-eluting stents in patients with Type 2 diabetes mellitus
by: K. N. Petrova, et al.
Published: (2008-10-01)

Correlationbetween the activity of lipoprotein-associated phospholipase A2 and blood lipid levels in hypertensive patients with different temperament and anxiety
by: G. A. Usenko, et al.
Published: (2014-12-01)

In Vitro Antiplasmodial Activity of Phospholipases A2 and a Phospholipase Homologue Isolated from the Venom of the Snake Bothrops asper
by: Juan Carlos Alarcón Pérez, et al.
Published: (2012-12-01)

Effect of phospholipase A2 inhibitors during infection caused by Leishmania (Leishmania) amazonensis
by: Maria L. A. C. Bordon, et al.
Published: (2018-08-01)

The crystallization and x-ray characterization of the phospholipase Ab2sgbs of Crotalus Adamanteus
by: Placilla, William John, 1952-
Published: (1976)

Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitus
by: Seema Garg, et al.
Published: (2015-01-01)

Lipoprotein-associated phospholipase A2 (Lp-PLA2) in acute coronary syndrome
by: Jabor, Bashar
Published: (2016)

Lipoprotein-associated phospholipase A2 in relation to lipid markers: A pan-India correlation study
by: Sandhya Iyer, et al.
Published: (2019-05-01)

Relationship between levels of Lp-PLA2 andpolymorphisms of I198T with coronary heart disease
by: Ling Zhang, et al.
Published: (2016-10-01)

Relationship between a concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of arterial wall in patients with low and moderate risk by SCORE scale
by: Saule Zhaksylykovna Urazalina, et al.
Published: (2011-09-01)

The measurement of lysosomal phospholipase A2 activity in plasma
by: Akira Abe, et al.
Published: (2010-08-01)

C2 domain membrane penetration by group IVA cytosolic phospholipase A2 induces membrane curvature changes[S]
by: Katherine E. Ward, et al.
Published: (2012-12-01)

Short Linear Motifs Characterizing Snake Venom and Mammalian Phospholipases A2
by: Caterina Peggion, et al.
Published: (2021-04-01)

Bee Venom Phospholipase A2: Yesterday’s Enemy Becomes Today’s Friend
by: Gihyun Lee, et al.
Published: (2016-02-01)

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?
by: Adrianos Nezos, et al.
Published: (2021-06-01)

Studies on the hydrolysis of phosphatidylcholine by phospholipase A2 (EC 3.1.1.4) in organic solvents
by: Misiorowski, Ronald Lloyd, 1938-
Published: (1974)

CYTOSOLIC PHOSPHOLIPASE A2 EXPRESSION PATTERNS IN BRAIN FOLLOWING THE TRAUMATIC BRAIN INJURY
by: Yang, Shuangni
Published: (2010)

Phospholipase A2 Activates Hemostasis
by: Thomas W. Stief
Published: (2007-01-01)

Characterization of the human patatin-like phospholipase familys⃞
by: Paul A. Wilson, et al.
Published: (2006-09-01)

Lipoprotein-associated phospholipase A2 (Lp-PLA2) – possible diagnostic and risk biomarker in chronic ischaemic heart disease
by: Adriana Diaconu, et al.
Published: (2021-01-01)

Role of Phospholipase A2 in Retrograde Transport of Ricin
by: Kirsten Sandvig, et al.
Published: (2011-09-01)

Changes of serum lipoprotein phospholipase A2 and CRP levels in patients with chronic periodontitis and hy⁃ perlipidemia after atorvastatin treatment
by: WANG Weilu, et al.
Published: (2017-07-01)